Local Infiltration Analgesia for Hip Arthroscopy

Pain Clinical Trial

Official title:

Effectiveness of Ultrasound Guided Hip Infiltration With Local Anesthetic Solution for Pain Control After Hip Arthroscopy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01454518
• Other study ID #: 11-08-003
• Status: Completed
• Phase: N/A
• First received: October 6, 2011
• Last updated: March 8, 2013
• Start date: October 2011
• Est. completion date: February 2013

Study information

• Verified date: March 2013
• Source: Saint Francis Care
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to examine if ultrasound guided infiltration of local anesthetic solution around the hip joint will provide effective pain control after hip arthroscopy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: February 2013
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• hip arthroscopy

• ages 18-80

Exclusion Criteria:

• history of neurological disease

• diabetes

• pregnancy

• neuropathy

• chronic narcotic use

• allergy to local anesthetic solution

• inability to give consent or cooperate with the study protocol

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pain

Intervention

Procedure:
• Infiltration of local anesthetic
30 ml of ropivacaine 0.5% infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.
• Normal Saline Injection
injection of 30ml normal saline infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.

Locations

Country	Name	City	State
United States	Saint Francis Hospital and Medical Center	Hartford	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
Saint Francis Care

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Post operative opioid consumption.	Amount in milligrams of opioid consumption post surgery in the recovery room and for a 24 hour period.	Within 24 hours after surgery	No
Secondary	Pain scores in recovery room.	Mesures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 24 hour period after discharge from recovery room.	Within 24 hours of the surgery	No